1/35
Looks like no tags are added yet.
Alberta apparent opioid toxicity deaths
Alberta is disproportionately affected by opioid deaths. Last year we had 1,145
Current unintentional acute drug poisoning deaths trend
Lowering, but still above pre-covid levels due to big changes in drug creation
Within alberta has the most opioid related overdoses
Edmonton
What percentage of individuals used a health care service within 30 days of a non-pharmaceutical opioid death?
53% (one of: antidepressants/antiolytic dispensed, ED visit, Opoiod dependency therapy)
Most common substances found involved in drug-induced death
Fentanyl ,Carfentanil, Methamphetamine
Most common liocations of unintentional opioid poisoning death
Personal residence, or public location
Risk of opioid related death after an ED visit
Mortality rate 3.5X higher for those who visited with an overdose related visit. Mortality 7.1X higher for those who left AMA
Timeline of opioid-related deaths following ED visit
Most deaths occured within 1 month of visit (20.5%)
Why are opioid related deaths so high following an ED visit?
Time spent in hospital can lower tolerance, meaning the first dose after being in the hospital has a higher risk of toxicity
Unintentional opoiod poisoning deaths in first natations people
Number of these deaths is is significantly higher epr capita in First nations people versus non-first nations people
DSM-5 diagnosis of opioid use disorder
Must fill out several criteria that include:
Taking more or for longer than intended
Repeated failed attemps to cut down or stop
Spending a lot of time obtaining, using, or recovering form use
Craving
Role failure (home, work, school obligations)
Persistant use despite relationship problems caused by it
Important activities given up or reduced by substance use
recurrent use in hazardous situations
Persistant use despite physical or psychological problems
Tolerance
Withdrawal symptoms
Opioud use disorder standard of care
Adults with opioid use disorder should have access to:
Opioid agonist treatment
Psychosocial supports
Safer use education
Safer use supplies
Take home naloxone kits
What drugs can be used in opioid agonist treatment (OAT)
Buprenorphine, methadone, slow-release oral morphine
What is Buprenorphine
High affinity, paetial agonist for the mu opioid receptor
Used in agonist treatment due to its ceiling effects for receptor mediated effects such as respiratory depression or euphoria
Buprenorphine
Slow dissociation kinetics (166 mins)
Half life 24-42 hours (transmucosal formulation)
Use of microinduction dosing of Suboxone (Buprenorphine/naloxone)
Used when patient needs to be on another opioid for pain. Then once the pain subsides you can switch purely over to Suboxone
Use of macro induction of Suboxone
Used when patient is in active withdrawal (used as a correction)
What is Subclocade
Buprenorphine extended release injection
Once monthly subcutaneous injection for patients stabilized on 8-24 mg of Suboxone for a minimum of 7 days
What is Methadone
Full agonist opioid with activity predominantly at the mu-opioid receptor
Some antagonist activity at the N-methyl-D-aspartate (NMDA)
Methadone kinetics
Peak plasma levels occur between 2.5-4 hours after ingestion
Variable elimination (22-48 hours) and takes time to reach steady state
Use of rapid titration of methadone
Used for individuals who have a higher tolerance
Methadone cautions
Multiple drug interactions
QTc prolongations
Increased risk of death during initiation and titration (first 2-4 weeks)
Narrow therapeutic index
Long elimination half life
OAT benefits on mortality
Rate of all cause mortality during OAT was halved. Lower risk for suicide, cancer, drug-related, and cardiovascular related mortality
No difference between methadone vs Buprenorphine
What is Kadian
Slow-release oral morpine
Full agonist opioid used for OAT when Methadone or Buprenorphine
Works similar to methadone in OAT
Kadian kinetics
Extensive but variable first pass metabolism, about 40% of the adiminstered dose reaches central component
Mean peak plasma concentration between 8.5-10 days. Steady state in about 2 days
Drawbacks of using slow release oral morphine for OAT
For patients with opioid use disorder, capsules are opened and ingestion must be witnessed in the pharmacy (must go to the pharmacy several times a day)
What is injectable opioid agonist treatment
High intensity treatment option for people with severe opioid use disorder where stabilixation has not occured with Methadone, Buprenorphine or oral morphine
Treatment is usually hydromorphone injection
Recovery oriented system of care for opioid use disorder
Counselling, peer supports, bed-based addiciton treatment. Collaborative approach, involve others as appropriate
Safety planning supports for opioid use disorder
Take home naloxone kit
Safer use education
New substance use equipment
Supervised consumption services
What is self stigma
Internalized negative messages about people who use drugs and apply them to themselves. It leads to low self esteem and feelings of shame
Effect of self stigma on opioid use disorder
Can cause someone to not access support because they fear being judged or discriminated against. This can cause someone to hide their drug use or use drugs alone
What is social stigma
Negative attitudes or behaviors towards people who use drugs or towards their friends or family members. Also includes negative labels in everydat conversation and in the media
What is structural stigma
Policies in health and social services that increase stigma, such as not providing services until drug use is better managed
Also includes workplace policies that cause harm and unintentionally encourage people hide their drug use to prevent them from seeking help
What are the 4 core issues found that help explaoni why people iwth substance use disorders leave the hospital prematurely
Undertreated withdrawal and ongoing cravings
Uncontrolled acute and chronic pain
Stigma and discrimination
Hospital retrictions
What is drug checking
Using paper spray MS to provide on-site drug checkig services at supervised consumption sites to allow users to know what is inside their drugs
What can helathcare workers do to improve treatment of opioid misuse/overuse?
Be a safe person to talk to about substance use
Educate yourself about substance use treatment and recovery
Understand how to ID and respond to someone experiecining an opioid poisoning